Mental Health Research Accelerator Act of 2025

Support for Medical Research: The bill provides a 25 percent credit for expenses necessary for translational research regarding neurodegenerative diseases and psychiatric conditions (Section 2(a)). This could encourage more research into these specific medical fields.

Focus on New Treatments: Regulations established by the Secretary will emphasize new therapeutics and devices targeted at central nervous system disorders (Section 2(b)(2)(D)(iii)).

Encouragement of Collaboration: The regulations include standards for public-private partnerships, giving priority to collaborative efforts and the sharing of intellectual property held by tax-exempt entities (Section 2(b)(2)(D)(v)).

Broad Research Scope: Research projects can include all phases of the research continuum and include standards for repurposing existing drugs and devices (Section 2(b)(2)(D)(ii) and (iv)).

Financial Limitations: There are specific limits on how much credit a taxpayer can receive and an aggregate national limitation that changes each year (Section 2(b)(1) and (b)(2)(A)).

Expiration of Benefits: The credit is not permanent, as no credit shall be allowed for any taxable year beginning after December 31, 2035 (Section 2(b)(e)).

Restriction on Deductions: A deduction is not allowed for the portion of expenses taken into account for the credit (Section 2(b)).